Citi Upgrades CardioNet (BEAT) to Buy
Tweet Send to a Friend
Citi upgrades CardioNet, Inc. (Nasdaq: BEAT) from Hold to Buy. Price target lowered from $35 to $30.
Citi ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE